Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Nov-Dec;32(6):661-2.
doi: 10.5144/0256-4947.2012.661.

Capecitabine-induced terminal ileitis

Aboelkhair Mohammad Al-Gahmi, Ian Graham Kerr, Jamal Mohamed Zekri, Abbas Abdulqader Zagnoon
Case Reports

Capecitabine-induced terminal ileitis

Aboelkhair Mohammad Al-Gahmi et al. Ann Saudi Med. 2012 Nov-Dec.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Colonoscopy showed isolated terminal ulceration.
Figure 2
Figure 2
The histopathology was consistent with inflammatory changes and eosinophilic infilterate but no evidence of malignancy, granulomas or CMV (cytomegalovirus).
See this image and copyright information in PMC

References

    1. Miwa M, Ura M, Nishada M, Sawada N, Ishikawa T, Mori K, Shimma N. Design of a novel oral fluoropyrimidine, capecitabine, which generates 5-fluorouracil selectively in tumors by enzymes concentrated in human liver and cancer tissue. Eur J cancer. 1998 Jul;34(8):1274–81. - PubMed
    1. Cassidy J, Twelves C, Van Cutsem E. First-line oral capecitabine therapy in metastatic colorectal cancer: A favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. Ann Oncol. 2002;13:566–575. - PubMed
    1. Barton Debora, Brazil, Cruz Marcelo, Brazil, Schraibman Vladimir. Ulcerative Ileitis Secondary to Adjuvant Capecitabine for Colon Cancer: A Case Report. UICC world Cancer Congress 2006)–abstract.
    1. Bouma G, Imholz A. Ileitis following capecitabine use. NedTijdschr Source :DeventerZiekenhuis, afd. InterneGeneeskunde, Deventer, the Netherlands. Geneeskd. 2011;155:A3064. - PubMed
    1. Hyodo I, Shirao K, Doi T, Hatake K, Arai Y, Yamaguchi K, Tamura T. A phase II Study of the global dose and schedule of capecitabine in Japanese patients with metastatic colorectal cancer. Jpn J ClinOncol. 2006;36(7):410–7. - PubMed

MeSH terms